1,4-Cineole

CAS No. 470-67-7

1,4-Cineole( Isocineole )

Catalog No. M24419 CAS No. 470-67-7

1,4-Cineole is a natural, oxygenated monoterpene. 1,4-Cineole can activate both human TRPM8 and human TRPA1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 33 In Stock
100MG 29 In Stock
200MG 41 In Stock
500MG 65 In Stock
1G 91 In Stock

Biological Information

  • Product Name
    1,4-Cineole
  • Note
    Research use only, not for human use.
  • Brief Description
    1,4-Cineole is a natural, oxygenated monoterpene. 1,4-Cineole can activate both human TRPM8 and human TRPA1.
  • Description
    1,4-Cineole is a natural, oxygenated monoterpene. 1,4-Cineole can activate both human TRPM8 and human TRPA1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Isocineole
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    Endogenous Metabolite|TRPA1|TRPM8
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    470-67-7
  • Formula Weight
    154.25
  • Molecular Formula
    C10H18O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 125 mg/mL (810.37 mM; Need ultrasonic)
  • SMILES
    CC(C12CCC(O2)(C)CC1)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Takaishi M, et al. 1,8-cineole, a TRPM8 agonist, is a novel natural antagonist of human TRPA1. Mol Pain. 2012 Nov 29;8:86.
molnova catalog
related products
  • Cytosine

    Cytosine is a pyrimidine base that is a fundamental unit of nucleic acids. The deamination of cytosine alone is apparent and the nucleotide of cytosine is the prime mutagenic nucleotide in leukaemia and cancer.

  • (R)-Pantetheine

    (R)-Pantetheine (Pantetheine) is the biologically active form of VB5 (pantothenic acid), which occurs in nature in various forms of Pantetheine-containing ligands (PCL).

  • L-(+)-Arabinose

    L-(+)-Arabinose inhibits intestinal sucrase activity, thereby reducing sucrose utilization, and consequently decreasing lipogenesis.